Background: Prior studies suggest sulci are more vulnerable to age- and Alzheimer's disease (AD)-related atrophy than gyri, but the pattern of regional vulnerability to tau pathology is incompletely understood. We performed this study to determine whether tau-related atrophy preferentially affects sulci and specifically the early-developing, deepest portions of sulci, which have been shown to be connectivity hubs.
Methods: We used MRI, amyloid and tau PET scans from 809 Alzheimer's Disease Neuroimaging Initiative participants: 92 with AD, 249 with MCI, 468 cognitively normal. Correlation between vertex-wise cortical thickness and whole-brain tau was performed using FreeSurfer's GLM pipeline. Following cluster-wise multiple comparisons correction, an ROI of significant clusters was generated ("clusters;" Fig. 1). Overlap between the clusters and whole-brain sulcal or gyral ROIs was calculated using the dice coefficient. We then generated labels of the deepest 5% of points in the sulcal ROI or the remaining 95%, as well as the deepest 5% of points of the superior temporal sulcus (STS) and collateral sulcus (COS, chosen as a control), and calculated their overlap with the clusters. For all comparisons we used mixed-effects ANOVAs to examine the effects of ROI (sulcal/gyral, deeper/shallower points, STS/COS) and hemisphere (left/right) on the amount of overlap with the clusters.
Results: Clusters of significant negative tau-thickness correlation overlap significantly (p<.0001) more with sulci than gyri (Fig. 2B). This overlap is also significantly (p<.0001) greater in the deepest sulcal points compared to the rest of the sulci (Fig. 2C). This effect was greater in the STS than COS (Fig. 3). There is a right hemisphere (RH) bias in this overlap, which is stronger for the STS.
Conclusions: We find that tau-related thinning occurs mostly in sulci, and particularly in sulcal depths. This overlap is particularly striking within the STS, a brain region particularly vulnerable to AD pathology and deeper in the RH. These results show greater specificity for sulcal vulnerability in aging and AD, particularly in the deepest parts of sulci. This anatomical specificity may underlie the profound effects of tau deposition on cognition.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.095011 | DOI Listing |
Clin EEG Neurosci
January 2025
Palma Sola Neurology Associates, Bradenton, FL, USA.
Evoked potential metrics extracted from an EEG exam can provide novel sources of information regarding brain function. While the P300 occurring around 300 ms post-stimulus has been extensively investigated in relation to mild cognitive impairment (MCI), with decreased amplitude and increased latency, the P200 response has not, particularly in an oddball-stimulus paradigm. This study compares the auditory P200 amplitudes between MCI (28 patients aged 74(8)) and non-MCI, (35 aged 72(4)).
View Article and Find Full Text PDFProteomics
January 2025
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alzheimer's disease (AD) is a leading cause of dementia, but the pathogenesis mechanism is still elusive. Advances in proteomics have uncovered key molecular mechanisms underlying AD, revealing a complex network of dysregulated pathways, including amyloid metabolism, tau pathology, apolipoprotein E (APOE), protein degradation, neuroinflammation, RNA splicing, metabolic dysregulation, and cognitive resilience. This review examines recent proteomic findings from AD brain tissues and biological fluids, highlighting potential biomarkers and therapeutic targets.
View Article and Find Full Text PDFJ Alzheimers Dis
January 2025
Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Background: Plasma biomarkers demonstrated potential in identifying amyloid pathology in early Alzheimer's disease. Different subtypes of subjective cognitive decline (SCD) may lead to different cognitive impairment conversion risks.
Objective: To investigate the differences of plasma biomarkers in SCD subtypes individuals, which were unclear.
J Alzheimers Dis
January 2025
Alzheimer Centrum Limburg, Mental Health and Neuroscience Research Institute (MHeNs), Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands.
Background: There is consistent evidence for the contribution of modifiable risk factors to dementia risk, offering opportunities for primary prevention. Yet, most individuals are unaware of these opportunities.
Objective: To investigate whether online education about dementia risk reduction may be a low-level means to increase knowledge and support self-management of modifiable dementia risk factors.
J Alzheimers Dis
January 2025
Department of Gerontology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: Urinary formic acid (FA) has been reported to be a biomarker for Alzheimer's disease (AD). However, the association between FA and pathological changes in memory clinic patients is currently unclear.
Objective: This study aims to investigate associations between FA and pathological changes across different cognitive statuses in memory clinic patients.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!